← Eichor
Condition: Rsv Immunization Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Rsv Immunization

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons
Phase 2 · 1 location(s) · Johns Hopkins University · NCT07050732An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During Their First RSV Season in the
Phase N/A · 1 location(s) · Sanofi · NCT07634692Safety of RSV Preventive Monoclonal Antibody
Phase 4 · 6 location(s) · Duke University · NCT07158814A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respirato
Phase 3 · 11 location(s) · University of Witwatersrand, South Africa · NCT06955728Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination
Phase 3 · 1 location(s) · Centre Hospitalier Annecy Genevois · NCT07232706A Study to Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults
NA · 1 location(s) · University of California, San Francisco · NCT07171164Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06881953Effectiveness And Impact Of Nirsevimab In Chile (NIRSE-CL)
Phase N/A · 1 location(s) · Instituto Sistemas Complejos de Ingeniería · NCT06511687RSV Immunisation Status in Queensland (Australia)
Phase N/A · 1 location(s) · Sanofi · NCT07615192RSV Immunogenicity Study in the Elderly (RISE)
Phase 3 · 2 location(s) · Karin Karin Loré · NCT07203365Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy
Phase 4 · 4 location(s) · Canadian Immunization Research Network · NCT07097012A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Sin
Phase 3 · 97 location(s) · Pfizer · NCT06866405RSV Vaccination in Immunocompromised Patients.
Phase 2 · 1 location(s) · Medical University of Vienna · NCT06597916Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization
Phase N/A · 1 location(s) · Federico Martinón Torres · NCT06180993Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
Phase N/A · 1 location(s) · Yale University · NCT06172660
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.